Vitamin E Derivative Particulate Formulation for Dust-Free Handling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pharmaceutical formulations using water-soluble vitamin E derivatives, such as TPGS, face challenges with tackiness, high fines content, caking, and phase separation, leading to storage instability and processing issues, particularly due to the waxy nature of TPGS and the use of organic solvents.
Innovation Solution
A storage-stable, dust-free, homogeneous particulate formulation comprising a water-soluble Vitamin E derivative, a hydrophilic polymer, and optional surface-active substances, manufactured through a spray granulation process, specifically spouted bed spray granulation, to produce particles with a low fines fraction and improved flowability, avoiding organic solvents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If water-soluble vitamin E derivatives (TPGS) are used to enhance solubility of hydrophobic active ingredients, then bioavailability is improved, but the material becomes tacky and difficult to handle
Solution Approach 1:
The patent changes the physical state of TPGS from liquid to solid by incorporating it into a solid matrix formed by hydrophilic polymers through freeze-drying. This parameter change from liquid to solid form eliminates tackiness while preserving the solubility-enhancing properties of TPGS
Solution Approach 2:
The patent creates a composite material system consisting of TPGS embedded in a hydrophilic polymer matrix (such as PVP, HPMC, or CMC). This composite structure combines the solubility-enhancing properties of TPGS with the flowability and stability of the polymer matrix, resolving the contradiction between bioavailability enhancement and handleability
2Reliability
If high amounts of surface-active substances are used to improve solubility, then bioavailability increases, but caking and phase separation occur during storage
Solution Approach 1:
The patent changes the physical state of the surface-active substance from liquid to solid by incorporating it into a solidified polymer matrix through freeze-drying. This prevents the phase separation and caking that occur in liquid or semi-solid formulations during storage
Solution Approach 2:
The patent extracts the problematic liquid/semi-solid phase that causes caking and phase separation, retaining only the solidified composite structure. The freeze-drying process removes the continuous liquid phase while preserving the dispersed TPGS particles within the polymer matrix
3Ease of manufacture
If organic solvents are used in manufacturing to process the waxy surfactant, then processability improves, but safety risks and residual solvent problems arise
Solution Approach 1:
The patent introduces water as an intermediary solvent instead of organic solvents. The hydrophilic polymer acts as a mediator that allows the waxy TPGS to be incorporated into the formulation through aqueous processing, eliminating the need for organic solvents while maintaining processability
Solution Approach 2:
The patent replaces chemical processing methods using organic solvents with a physical processing method (freeze-drying) that uses water and temperature control. This substitution eliminates harmful organic solvents while maintaining the ability to process the waxy surfactant
4Ease of manufacture
If mechanical processing methods are used to handle the waxy material, then formulation is achieved, but fines content increases causing dust and blocking issues
Solution Approach 1:
The patent changes the processing method from mechanical mixing and grinding to freeze-drying, which is a gentle physical process that does not generate fines. The phase transition from liquid to solid during freeze-drying creates a cohesive structure that prevents particle breakdown and dust formation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation achieves enhanced storage stability, free-flowing properties, and improved processability, reducing the risk of caking and phase separation, while ensuring safety by eliminating organic solvents and minimizing fines content, thus facilitating reliable pharmaceutical formulation manufacturing.
Implementation Method 1
contacting the atomized solution with a fluidized bed of fines of a particulate material
Implementation Method 2
atomizing said solution with the help of one or more spray nozzles
Data Source
AI summary
A storage-stable dust-free homogeneous particle formulation, consisting of (a) at least one water-soluble Vitamin E-derivative, (b) at least one hydrophilic polymer, (c) optionally additional surface-active substances, and (d) optionally additional pharmaceutical additives, with the proviso, that the sum of (a), (b), (c) and (d) equals 100 % by weight of the formulation, and wherein the fines fraction with particle diameters of less than 100 μm is less than 10 % by weight.